1224436-76-3

Basic information

• Product Name: (2S,3S,4R)-1-(tert-butyldiphenylsilyloxy)-2-[N-(tert-butyloxycarbonyl)amino]octadecan-3,4-diol
• Synonyms: (2S,3S,4R)-1-(tert-butyldiphenylsilyloxy)-2-[N-(tert-butyloxycarbonyl)amino]octadecan-3,4-diol
• CAS NO: 1224436-76-3
• Molecular Weight: 656.034
• Mol File: 1224436-76-3.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: (2S,3S,4R)-1-(tert-butyldiphenylsilyloxy)-2-[N-(tert-butyloxycarbonyl)amino]octadecan-3,4-diol(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S,4R)-1-(tert-butyldiphenylsilyloxy)-2-[N-(tert-butyloxycarbonyl)amino]octadecan-3,4-diol(1224436-76-3)
• EPA Substance Registry System: (2S,3S,4R)-1-(tert-butyldiphenylsilyloxy)-2-[N-(tert-butyloxycarbonyl)amino]octadecan-3,4-diol(1224436-76-3)

Safety Data

• Hazardous Substances Data: 1224436-76-3(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 175696-50-1 tert-butyl [(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]carbamate 
• 554-62-1 D-ribo-phytosphingosine 
• 1224436-75-2 (2S,3S,4R)-2-amino-1-((tert-butyldiphenylsilyl)oxy)octadecane-3,4-diol 

Downstream Products

• 1226980-98-8 (S)-4-[(1S,2R)-2-(tert-butyldiphenylsilyloxy)-1-hydroxyhexadecyl]oxazolidin-2-one 
• 1226981-00-5 (S)-4-[(1S,2R)-1-(tert-butyldiphenylsilyloxy)-2-hydroxyhexadecyl]oxazolidin-2-one 
• 1224436-77-4 C₅₃H₇₃NO₇Si 
• 1262283-53-3 C₃₉H₆₃NO₆SSi 
• 1262283-52-2 (2S,3S,4R)-1-(tert-butyldiphenylsilyloxy)-2-[N-(tert-butyloxycarbonyl)amino]octadecan-3,4-cyclic sulfate 
• 1262283-54-4 (4S,5R)-4-((tert-butyldiphenylsilyloxy)methyl)-5-((R)-1-hydroxypentadecyl)oxazolidin-2-one 
• 1262283-55-5 (4S,5S,6S)-4-((tert-butyldiphenylsilyloxy)methyl)-5-hydroxy-6-tetradecyl-1,3-oxazinan-2-one 
• 1262283-61-3 (R)-1-((4S,5R)-4-((tert-butyldiphenylsilyloxy)methyl)-2-oxooxazolidin-5-yl)pentadecyl methanesulfonate 
• 1262283-60-2 (4S,5S,6S)-4-((tert-butyldiphenylsilyloxy)methyl)-2-oxo-6-tetradecyl-1,3-oxazinan-5-yl methanesulfonate 
• 1262283-63-5 (4S,5S,6S)-4-((tert-butyldiphenylsilyloxy)methyl)-2-oxo-6-tetradecyl-1,3-oxazinan-5-yl trifluoromethanesulfonate 
• 1262283-59-9 (2S,3S,4R)-1-(tert-butyldiphenylsilyloxy)-2-[N-(tert-butyloxycarbonyl)amino]octadecan-3,4-diol dimethanesulfonate 

Relevant articles and documents

4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

Disclosed are halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections. Such viral infections can include tongaviridae, bunyaviridae, arenaviridae, coronaviridae, flaviviridae, picornaviridae, Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infections.

NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the base of the nucleotide or nucleoside contains at least one thiol, thione or thioether.

ALKYNE CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the base of the nucleotide or nucleoside contains at least one thiol, thione or thioether.